ESMO 2026 Presidential Symposia: From Trial Results to Clinical Implications
Phase II Trial Shows Promising Pathologic Responses With Neoadjuvant Nivolumab and Chemotherapy in Salivary Gland Cancer
OncoDaily and Natera Present “Seismic Shift: Innovations in MRD Testing and Pathology”
High CA-125 Levels: Causes, Normal Range and Cancer Risk
Sara Tolaney: Breast Cancer Insights From ESMO 2026
A National Multidisciplinary BC Course Has Trained 180 Clinicians Across Mongolia - UICC
ESMO 2026: What’s New in Melanoma Immunotherapy?
NEOASIS at ESMO 2026: Neoadjuvant Botensilimab Plus Balstilimab in dMMR Colorectal Cancer
The Keystone Symposia – Cancer Neuroscience: Neural Mechanisms as Therapeutic Targets in Cancer 2027 conference will take place on February 21–24, 2027, at Keystone Resort in Keystone, Colorado, United States. […]
